dr. M.M.J. van Greevenbroek PhD
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
["EP PerMed"], EU-Calprotect: Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes, zonmw-11180102410005-48791, 2025–2028, 1 Apr 2025
Sources: openalex.org